Metraipolis › archive › dc_1aefdcc701c8

A real-world data analysis of Ozanimod in the FDA Adverse Event Reporting System (FAERS) database — Europe PMC PMID:40958239

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40958239
DOI
10.1097/md.0000000000044535
License (as archived)
solo-consultazione
Archived
2026-10-08T14:29:58.754Z
SHA-256 of the archived text
8491461fe57491aba292264619782ea33c698467b08fff64cbad24fab48ed467
Stable URL of this page
https://metraipolis.com/documento/dc_1aefdcc701c8

How to cite

A real-world data analysis of Ozanimod in the FDA Adverse Event Reporting System (FAERS) database — Europe PMC PMID:40958239 — Europe PMC (en), https://europepmc.org/article/MED/40958239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1aefdcc701c8 (Metraipolis archive dc_1aefdcc701c8, sha256 8491461fe57491aba292264619782ea33c698467b08fff64cbad24fab48ed467)
BibTeX
@misc{dc1aefdcc701c8,
  title = {A real-world data analysis of Ozanimod in the FDA Adverse Event Reporting System (FAERS) database — Europe PMC PMID:40958239},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40958239},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1aefdcc701c8; sha256 8491461fe57491aba292264619782ea33c698467b08fff64cbad24fab48ed467},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40958239. Agents can read the archived copy with the MCP tool read_document.